Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 1
2005 1
2006 2
2007 8
2008 1
2009 4
2010 5
2011 4
2012 1
2013 3
2014 2
2015 4
2016 8
2017 5
2018 10
2019 6
2020 5
2021 7
2022 10
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Musella M, Guarracino A, Manduca N, Galassi C, Ruggiero E, Potenza A, Maccafeo E, Manic G, Mattiello L, Soliman Abdel Rehim S, Signore M, Pietrosanto M, Helmer-Citterich M, Pallocca M, Fanciulli M, Bruno T, De Nicola F, Corleone G, Di Benedetto A, Ercolani C, Pescarmona E, Pizzuti L, Guidi F, Sperati F, Vitale S, Macchia D, Spada M, Schiavoni G, Mattei F, De Ninno A, Businaro L, Lucarini V, Bracci L, Aricò E, Ziccheddu G, Facchiano F, Rossi S, Sanchez M, Boe A, Biffoni M, De Maria R, Vitale I, Sistigu A. Musella M, et al. Among authors: fanciulli m. Nat Immunol. 2022 Sep;23(9):1379-1392. doi: 10.1038/s41590-022-01290-3. Epub 2022 Aug 24. Nat Immunol. 2022. PMID: 36002648 Free PMC article.
Deptor: not only a mTOR inhibitor.
Catena V, Fanciulli M. Catena V, et al. Among authors: fanciulli m. J Exp Clin Cancer Res. 2017 Jan 13;36(1):12. doi: 10.1186/s13046-016-0484-y. J Exp Clin Cancer Res. 2017. PMID: 28086984 Free PMC article. Review.
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Ricciardi E, Giordani E, Ziccheddu G, Falcone I, Giacomini P, Fanciulli M, Russillo M, Cerro M, Ciliberto G, Morrone A, Guerrisi A, Valenti F. Ricciardi E, et al. Among authors: fanciulli m. Int J Mol Sci. 2023 Feb 16;24(4):4014. doi: 10.3390/ijms24044014. Int J Mol Sci. 2023. PMID: 36835424 Free PMC article. Review.
ZFP750 affects the cutaneous barrier through regulating lipid metabolism.
Butera A, Agostini M, Cassandri M, De Nicola F, Fanciulli M, D'Ambrosio L, Falasca L, Nardacci R, Wang L, Piacentini M, Knight RA, Jia W, Sun Q, Shi Y, Wang Y, Candi E, Melino G. Butera A, et al. Among authors: fanciulli m. Sci Adv. 2023 Apr 28;9(17):eadg5423. doi: 10.1126/sciadv.adg5423. Epub 2023 Apr 28. Sci Adv. 2023. PMID: 37115925 Free PMC article.
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.
Bruno T, Catena V, Corleone G, Cortile C, Cappelletto MC, Bellei B, De Nicola F, Amadio B, Gumenyuk S, Marchesi F, Annibali O, Blandino G, Fanciulli M, Di Agostino S. Bruno T, et al. Among authors: fanciulli m. Leukemia. 2024 Apr;38(4):877-882. doi: 10.1038/s41375-024-02168-z. Epub 2024 Feb 17. Leukemia. 2024. PMID: 38368441 Free PMC article. No abstract available.
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
Bazzichetto C, Conciatori F, Pallocca M, Falcone I, Fanciulli M, Cognetti F, Milella M, Ciuffreda L. Bazzichetto C, et al. Among authors: fanciulli m. Cancers (Basel). 2019 Mar 28;11(4):435. doi: 10.3390/cancers11040435. Cancers (Basel). 2019. PMID: 30925702 Free PMC article. Review.
101 results